Use of Antiviral Agents and other Therapies for COVID-19

被引:3
作者
Blaskovich, Mark A. T. [1 ,2 ]
Verderosa, Anthony D. [1 ]
机构
[1] Univ Queensland, Inst Mol Biosci, Ctr Superbug Solut, St Lucia, Qld, Australia
[2] Univ Queensland, Inst Mol Biosci, Ctr Superbug Solut, 306 Carmody Rd Bldg 80, St Lucia, Qld 4072, Australia
关键词
COVID-19; SARS-CoV-2; antiviral; protease inhibitor; polymerase inhibitor; EPIDEMIC PREPAREDNESS; PROTEASE INHIBITOR; IVERMECTIN; HYDROXYCHLOROQUINE; CHLOROQUINE; ENTRY;
D O I
10.1055/s-0042-1758837
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The coronavirus disease 2019 (COVID-19) pandemic led to a remarkably rapid development of a range of effective prophylactic vaccines, including new technologies that had not previously been approved for human use. In contrast, the development of new small molecule antiviral therapeutics has taken years to produce the first approved drugs specifically targeting severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), with the intervening years filled with attempts to repurpose existing drugs and the development of biological therapeutics. This review will discuss the reasons behind this variation in timescale and provide a survey of the many new treatments that are progressing through the clinical pipeline.
引用
收藏
页码:118 / 129
页数:12
相关论文
共 82 条
[41]   Hydroxychloroquine in the prevention of COVID-19 mortality [J].
Jorge, April .
LANCET RHEUMATOLOGY, 2021, 3 (01) :E2-E3
[42]  
Kolata G., 2020, NEW YORK TIMES
[43]   RETRACTED: Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19 (Publication with Expression of Concern) (Retracted Article) [J].
Kory, Pierre ;
Meduri, Gianfranco Umberto ;
Varon, Joseph ;
Iglesias, Jose ;
Marik, Paul E. .
AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (03) :E299-E318
[44]   Ivermectin - Old Drug, New Tricks? [J].
Laing, Roz ;
Gillan, Victoria ;
Devaney, Eileen .
TRENDS IN PARASITOLOGY, 2017, 33 (06) :463-472
[45]   The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable [J].
Lawrence, Jack M. ;
Meyerowitz-Katz, Gideon ;
Heathers, James A. J. ;
Brown, Nicholas J. L. ;
Sheldrick, Kyle A. .
NATURE MEDICINE, 2021, 27 (11) :1853-1854
[46]   Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications [J].
Levin, Andrew T. ;
Owusu-Boaitey, Nana ;
Pugh, Sierra ;
Fosdick, Bailey K. ;
Zwi, Anthony B. ;
Malani, Anup ;
Soman, Satej ;
Besancon, Lonni ;
Kashnitsky, Ilya ;
Ganesh, Sachin ;
McLaughlin, Aloysius ;
Song, Gayeong ;
Uhm, Rine ;
Herrera-Esposito, Daniel ;
de los Campos, Gustavo ;
Pecanha Antonio, Ana Carolina Pecanha ;
Tadese, Enyew Birru ;
Meyerowitz-Katz, Gideon .
BMJ GLOBAL HEALTH, 2022, 7 (05)
[47]   Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro [J].
Liu, Jia ;
Cao, Ruiyuan ;
Xu, Mingyue ;
Wang, Xi ;
Zhang, Huanyu ;
Hu, Hengrui ;
Li, Yufeng ;
Hu, Zhihong ;
Zhong, Wu ;
Wang, Manli .
CELL DISCOVERY, 2020, 6 (01)
[48]   Broad-Spectrum In Vitro Antiviral Activity of ODBG-P-RVn: An Orally-Available, Lipid-Modified Monophosphate Prodrug of Remdesivir Parent Nucleoside (GS-441524) [J].
Lo, Michael K. ;
Shrivastava-Ranjan, Punya ;
Chatterjee, Payel ;
Flint, Mike ;
Beadle, James R. ;
Valiaeva, Nadejda ;
Murphy, Joyce ;
Schooley, Robert T. ;
Hostetler, Karl Y. ;
Montgomery, Joel M. ;
Spiropoulou, Christina F. .
MICROBIOLOGY SPECTRUM, 2021, 9 (03)
[49]   Crystallization of Feline Coronavirus Mpro With GC376 Reveals Mechanism of Inhibition [J].
Lu, Jimmy ;
Chen, Sizhu Amelia ;
Khan, Muhammad Bashir ;
Brassard, Raelynn ;
Arutyunova, Elena ;
Lamer, Tess ;
Vuong, Wayne ;
Fischer, Conrad ;
Young, Howard S. ;
Vederas, John C. ;
Lemieux, M. Joanne .
FRONTIERS IN CHEMISTRY, 2022, 10
[50]   Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis [J].
Manabe, Toshie ;
Kambayashi, Dan ;
Akatsu, Hiroyasu ;
Kudo, Koichiro .
BMC INFECTIOUS DISEASES, 2021, 21 (01)